BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//London Global Cancer Week - ECPv6.18.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.lgcw.org.uk
X-WR-CALDESC:Events for London Global Cancer Week
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20211115T170000
DTEND;TZID=Europe/London:20211115T185000
DTSTAMP:20211113T141409Z
CREATED:20210519T193321Z
LAST-MODIFIED:20211113T141409Z
UID:10000050-1636995600-1637002200@www.lgcw.org.uk
SUMMARY:Cancer care - a balance of costs  Hosted by: Royal Society of Medicine Oncology Group
DESCRIPTION:Register \nCancer care – a balance of costs\nSpeakers\nAjay Aggarwal\nDr Ajay Aggarwal is a Consultant Clinical Oncologist at Guy’s & St Thomas’ NHS Trust\, London and Associate Professor at the London School of Hygiene and Tropical Medicine. His main research areas are Health Services Research and Global Health.   \nHe has been the recipient of two fellowship awards from the National Institute for Health Research (NIHR) in 2014 and 2020. In his role as the Oncology Coordinator for the UK National Prostate Cancer Audit\, he co-led the development and delivery of the first ever national hospital outcome reporting programme for radiotherapy.  \nHis research has contributed significantly to national and international policy discussion around the affordability of cancer care and the value of new technologies in cancer medicine which has influenced directly the WHO Cancer Drug Pricing and Benefits Taskforces. As co-chair of the Health Economics in Radiation Oncology (HERO) group within ESTRO (European Society for Radiation Oncology)\, he is leading the value-based health care initiative and working with the European Commission to support reimbursement policy for medical devices in cancer care. He has previously worked at the World Health Organisation in Geneva\, and has ongoing global health projects in South Africa\, Botswana and Zambia aimed at building radiotherapy capacity and cancer research capability.  \nDr. Dorothy Chilambe Lombe\nDr. Dorothy Chilambe Lombe is a clinical oncologist with sub-specialisation in brachytherapy. She is a Fellow of the College of Radiation Oncologists Colleges of Medicine South Africa\, holds a Master of Medicine degree in Radiation Oncology from Stellenbosch University and primary medical degree from Rostov State Medical University\, Russia.  \nShe has served as Chair of the Cervical Cancer Committee of the National Cancer Technical Working Group in Zambia and is a member of the National Cancer Control Strategic Plan Development Working Group. Internationally is a member of the COVID-19 and Cancer Global Taskforce\, WHO essential medicines list working group for cancer\, ASCO resource and ASCO International Liaisons Program.  \nIn establishing an independent research career she continues to investigate the application of ultrasound based imaging in the radiotherapy process for resource limited environments as well as understanding barriers to quality oncology care. In her spare time she writes a weekly features article on cancer for the local Times of Zambia newspaper and volunteers for the Zambian Cancer Society as part of her advocacy work. \nDr C S Pramesh\nDr C S Pramesh is the Director of the Tata Memorial Hospital and the Professor and Head of Thoracic Surgery at the Tata Memorial Centre\, Mumbai. He serves on the Board of Directors of the Union for International Cancer Control (UICC). He is the convener for the National Cancer Grid\, a large network of 244 cancer centres in India (https://tmc.gov.in/ncg). The mandate of the National Cancer Grid is to provide uniform standards of cancer care across the country. Pramesh is highly committed to efforts towards reducing inequities in cancer care and making cancer treatment accessible to all geographic regions and strata of society. He is also a visiting professor at the Division of Cancer Studies\, King’s College London and the Institute of Cancer Policy\, King’s Health Partners\, London. \nHis clinical interests include the management of esophageal and lung cancers. He is the Principal Investigator in several investigator-initiated research studies including randomized trials on cancer screening\, surgical techniques\, neoadjuvant and adjuvant treatment of thoracic cancers. His broader research interests include cancer policy\, health equity\, value-based care and health services research. He has more than 200 peer-reviewed journal articles\, abstracts and book chapters on various topics including thoracic oncology\, clinical research methods\, translational research\, health equity\, and cancer policy. \nProf Pramesh has strong interests in clinical trial designs\, surgical trials\, comparative effectiveness research\, promoting collaborative research and cancer policy. He is a Post-Graduate Diplomate in Clinical Trials from the London School of Hygiene and Tropical Medicine\, University of London. He is keen on promoting training in clinical research methods and conducts several courses on clinical research methodology\, biostatistics and scientific writing. He serves on the advisory boards of several national and international research organizations and granting agencies. \n  \n  \n 
URL:https://www.lgcw.org.uk/event/cancer-control-in-low-and-middle-income-countries-hosted-by-royal-society-of-medicine-oncology-group/
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/RSM-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201116T123000
DTEND;TZID=Europe/London:20201116T170000
DTSTAMP:20201113T141658Z
CREATED:20200626T145138Z
LAST-MODIFIED:20201113T141658Z
UID:10000022-1605529800-1605546000@www.lgcw.org.uk
SUMMARY:Oncology in low-middle income settings: The impact of the COVID-19 pandemic Hosted by: Royal Society of Medicine Oncology Group
DESCRIPTION:Register Here \nHosted by the Royal Society of Medicine Oncology Group\nSpeakers: \n\nProfessor Warren Phipps\, M.D.\, M.P.H. Medical Director\, UCI-Fred Hutch Collaboration UCI/Hutchinson Center Cancer Alliance\, Kampala\, Uganda\nDr May Abdel-Wahab\, Director\, Human Health Programme\, International Atomic Energy Agency\, Vienna\, Austria\nMs Isabel Mestres\, Director\, Global Public Affairs\, City Cancer Challenge\, Geneva\, Switzerland\nDr Hannah Tharmalingam\, Vice-President\, Clinical Oncology\, Royal College of Radiologists\, London\, United Kingdom\nDr Partha Basu\, Head\, Screening Group\, International Agency for Research on Cancer\nDr Ophira Ginsburg\, Associate Professor\, Section for Global Health\, Department of Population Health\, New York University\, United States\nProfessor Karen Canfell\, Director\, Cancer Research Division\, Cancer Council\, New South Wales\, Australia\nProfessor Mary Gospodarowicz\, Clinician Investigator\, Princess Margaret Cancer Centre\, Toronto\, Canada\nDr Verna Vanderpuye\, National Center for Radiotherapy and Nuclear Medicine\, Korle-Bu Teaching Hospital\, Accra\, Ghana\nDr Manjit Dosanjh\, Honorary CERN Staff\, European Organization for Nuclear Research (CERN)\, Switzerland; Visiting Professor\, University of Oxford and Project Leader\, STELLA (Smart Technologies to Extend Lives with Linear Accelerators)\nProfessor Bente Mikkelsen\, Director\, World Health Organization\, Geneva\, Switzerland\n\n 
URL:https://www.lgcw.org.uk/event/royal-society-of-medicine-oncology-group-the-impact-of-covid-19-on-cancer-management-in-low-and-middle-income-settings/
ATTACH;FMTTYPE=image/jpeg:https://www.lgcw.org.uk/wp-content/uploads/2020/06/RSM-HORZ-full-2-Colour-01.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20191128T100000
DTEND;TZID=Europe/London:20191128T130000
DTSTAMP:20191006T131542Z
CREATED:20190829T192122Z
LAST-MODIFIED:20191006T131542Z
UID:10000017-1574935200-1574946000@www.lgcw.org.uk
SUMMARY:Cancer in the Commonwealth
DESCRIPTION:
URL:https://www.lgcw.org.uk/event/cancer-in-the-commonwealth/
LOCATION:Marlborough House\, Pall Mall\, London\, SW1Y 5HX
ATTACH;FMTTYPE=image/jpeg:https://www.lgcw.org.uk/wp-content/uploads/2019/10/cancer-common-invite.jpg
END:VEVENT
END:VCALENDAR